The use of the vaccine designed by the American laboratory Johnson & Johnson is suspended definitively in Denmark and temporarily in the United States as well as in South Africa. It is now Belgium’s turn to postpone vaccination with this serum.
Why this decision?
Like the Anglo-Swedish AstraZeneca vaccine, rare cases of severe thrombosis have been reported after injection of the Janssen Johnson & Johnson vaccine. The Belgian government has therefore decided to delay the administration of this serum to its population, while the investigation takes place. Indeed, the European Medicines Agency must deliver its opinion during the week of April 19. The kingdom of Belgium was to begin its campaign with the Janssen Johnson & Johnson vaccine this Friday, April 16.
The pharmaceutical company, which wishes to provide clear and transparent information, also announced earlier this week that the deployment of its vaccines would be postponed in Europe, while the investigations are taking place.
France, for its part, is pursuing its strategy, “ as expected And said the Johnson & Johnson vaccine was intended for people over the age of 55.
